Share on

Middle East & Africa Articaine Hydrochloride Market Research Report - Segmented By Application, End User & Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) - Industry Analysis, Size, Share, Growth, Trends, & Forecasts (2023 to 2028)

Published: March, 2023
ID: 6212
Pages: 145
Formats: report pdf report excel report power bi report ppt

Middle and Africa Articaine Hydrochloride Market Size & Growth (2023 to 2028):

As per the research report, the size of the Middle East and Africa Articaine Hydrochloride market is valued at USD 0.14 billion in 2023 and is expected to reach USD 0.18 billion by 2028 to grow at 5.49% CAGR during the forecast period 2023 to 2028.

Increased dental caries and other periodontal diseases are expected to fuel the growth of the articaine hydrochloride market in the Middle East and Africa.

The most common local anesthetic in dentistry is articaine hydrochloride. The expansion of the articaine hydrochloride market is fuelled by the innovation of the dental anesthesia delivery system device and the inventive nature of the dental anesthesia sector. Periodontal disease is a common dental problem that affects people worldwide. In the Middle East and Africa, periodontitis is more common. One of the market's key reasons is the increased knowledge of preventative and corrective treatments. The articaine hydrochloride market is a novel management system that motivates dental specialists to run more efficient operations and provide better clinical care.

Increased incidences of dental caries and other periodontal diseases, advancements in dental anesthesia delivery system devices, increased use of articaine for dental surgery, the innovative nature of the dental anesthetics industry, and aggressive research and development efforts are expected to drive market growth. Periodontal disease is a common dental ailment that affects people worldwide.

The industry for articaine hydrochloride is booming. Articaine has been a popular local anesthetic in various markets due to its higher ability to disperse into tissues.

The lack of primary oral health education and the limited availability of simple therapies like pain medication and emergency care for acute infections and injuries, particularly in rural regions, are the key factors limiting the market's growth.

Articaine, in particular Butyryl Cholinesterase, is dependent on cholinesterase group enzymes to metabolize properly (BuChE). Articaine HCl is not broken down in the way it is supposed to be when there are insufficient levels of this enzyme or insufficiently effective enzymes in the body; thus, the body looks for other ways to get rid of it. Toxic by-products are formed due to this alternate metabolic process, resulting in paralysis or brain damage.

This research report on the MEA Articaine Hydrochloride Market has been segmented and sub-segmented into the following categories:

By Application:

  • Infiltration
  • Nerve Block
  • Others

By End User:

  • Dental Clinics
  • Hospitals
  • Academic
  • Research Institutes

By Country:

  • KSA
  • UAE
  • Israel
  • rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

In the Middle East and Africa, the global market is developing and will continue to rise steadily. As a result, governments have set price controls and import restrictions to stimulate domestic pharmaceutical firms and create a more stable economic environment. In addition, they require country-specific naming to reduce fraudulent and parallel imports. Import, wholesale, and retail laws have also been altered. 

In the pharmaceutical industry, pharmacies are merging, flat and vertical coordination is increasing, and output is increasing. Thanks to a frenzy of mergers and acquisitions, joint ventures, strategic alliances, associations, and private-sector partnerships, the Middle East and Africa's articaine commercial sectors are booming.

Saudi Arabia's articaine hydrochloride market is likely to grow in the Middle East and Africa region during the forecast period. Increased incidences of dental caries and other periodontal diseases, advancements in dental anesthesia delivery system devices, increased use of articaine for dental surgery, the innovative nature of the dental anesthetics industry, and aggressive research and development efforts are all expected to fuel market growth.

South Africa articaine hydrochloride market is expected to dominate the Middle East and Africa Articaine Hydrochloride market. The region's high prevalence of periodontal diseases is owing to a lack of primary oral health education and limited access to simple remedies like pain relief and emergency care for acute infection and trauma for the great majority of the population, particularly in rural areas.

KEY MARKET PLAYERS

Leading companies leading in the MEA Articaine Hydrochloride Market profiled in the report are 3M, Anhui BBCA Pharmaceutical Co., Ltd., Dentsply Sirona, Inibsa Dental S.L.U, Jinan Chenghui Shuangda Chemical Co., Ltd, Jinan Ruixing Pharmaceutical Technology Co., Ltd, Manus Aktteva Biopharma LLP, Pfizer Inc, Pierrel S.p.A, Sanofi, Septodont, Siegfried AG, and Sigma Aldrich.,

Please wait. . . . Your request is being processed

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000

Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM

Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!

REACH OUT TO US

Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: [email protected]

Click for Request Sample